Cargando…
Discovery, synthesis and mechanism study of 2,3,5-substituted [1,2,4]-thiadiazoles as covalent inhibitors targeting 3C-Like protease of SARS-CoV-2
The 3C-like protease (3CL(pro)) is essential for the replication and transcription of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), making it a promising target for the treatment of corona virus disease 2019 (COVID-19). In this study, a series of 2,3,5-substituted [1,2,4]-thiadiazole...
Autores principales: | Ren, Pengxuan, Yu, Changyue, Zhang, Ruxue, Nie, Tianqing, Hu, Qiaoyu, Li, Hui, Zhang, Xianglei, Zhang, Xueyuan, Li, Shiwei, Liu, Lu, Dai, Wenhao, Li, Jian, Xu, Yechun, Su, Haixia, Zhang, Leike, Liu, Hong, Bai, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847367/ https://www.ncbi.nlm.nih.gov/pubmed/36702052 http://dx.doi.org/10.1016/j.ejmech.2023.115129 |
Ejemplares similares
-
In silico screening-based discovery of novel covalent inhibitors of the SARS-CoV-2 3CL protease
por: Xiong, Muya, et al.
Publicado: (2022) -
Synthesis and Biological Activity of 3-(2-Furanyl)-6-Aryl-1,2,4-Triazolo[3,4-b]-1,3,4 –Thiadiazoles
por: Zhang, Li-Xue, et al.
Publicado: (2002) -
Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease
por: Su, Haixia, et al.
Publicado: (2021) -
Dimethylbis(3-methylsulfanyl-1,2,4-thiadiazole-5-thiolato)tin(IV)
por: Zhang, Junhong, et al.
Publicado: (2009) -
Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment
por: Jiang, Zhidong, et al.
Publicado: (2023)